# ContraBand™: Safety & Feasibility Study (RM-20-01)

> **NCT05230745** · NA · RECRUITING · sponsor: **Restore Medical Ltd** · enrollment: 55 (estimated)

## Conditions studied

- Heart Failure, Left Sided

## Interventions

- **DEVICE:** ContraBand implants

## Key facts

- **NCT ID:** NCT05230745
- **Lead sponsor:** Restore Medical Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-28
- **Primary completion:** 2029-06-30
- **Final completion:** 2032-12-31
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05230745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05230745, "ContraBand™: Safety & Feasibility Study (RM-20-01)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05230745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*